from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0721/rpsE

LFCtreatmentdescriptionclass of inhibitor

-0.358

Amikacinug/mL Amikacintranslation

-0.904

Cap5-10ug/mL Capreomycintranslation

-0.872

Rox10-50 ug/mL Roxithromycintranslation

1.000

SM2-5 ug/mL Streptomycintranslation

0.815

Tet5-10 ug/mL Tetracyclinetranslation

-0.039

Rif0.2-5ug/mL Rifampicintranscription

0.051

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.587

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.007

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.144

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.387

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.827

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.461

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.839

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.144

Nigericin50 uM Nigericinrespiration

-1.029

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.795

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.929

menadione6-10 ug/mL Menadionerespiration

-0.827

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.043

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.403

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.147

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.991

NRP_1Non-replicating persistence stage 1dosRassociated

0.527

Amp0.2mg/mL AmpicillincellWall

0.715

Cephalexin20-100 ug/mL CephalexincellWall

0.133

Cerulenin0.32-5 ug/mL CerulenincellWall

0.660

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.678

EMB10-20 ug/mL EthambutolcellWall

0.579

Eta12-40 ug/mL EthionamidecellWall

1.480

INH0.2-0.4 ug/mL IsoniazidcellWall

0.510

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.114

BZA0.12 mg/mL BenzamidearomaticAmides

-0.641

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.063

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.168

H2O24 mM hydrogen peroxideDNAdamaging

-0.235

Levo10 ug/mL LevofloxacinDNAdamaging

0.740

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.499

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.902

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.388

Antimycin12.5-50 ug/mL Antimycin A?

0.178

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.259

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.420

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.205

PA8240.2-2 ug/mL PA-824?

-0.982

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.571

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.485

Verapamil50 uM Verapamil?

0.981

mercaptoethanol2 mM 2-Mercaptoethanol?

1.455

methoxatin10-20 ug/mL Methoxatin?